Walgreens, based in Deerfield, Illinois, is launching the Medicare GLP-1 Bridge program to assist over 56 million patients in the Medicare network who could qualify for GLP-1 medications. This initiative will be available at nearly 8,000 Walgreens stores nationwide. Eligible Medicare patients can consult Walgreens pharmacists to guide them through the program. To participate, patients are advised to discuss potential eligibility with their healthcare provider. The Medicare Bridge program aims to streamline access to GLP-1 medications for qualifying individuals across the United States.